8th August 2019
In 2014, the charity Bloodwise awarded a 5-year programme grant to a team from Queen Mary University of London to support research to better understand the nature of the faulty genes responsible for an inherited/familial predisposition to MDS/AML.
Read more16th May 2019
Recent findings from a study published in JAMA Oncology have identified genetic markers within blood samples which may indicate whether patients with prostate cancer will respond to hormonal therapies. The study may represent an important step forward for the development of more personalised treatments for advanced prostate cancer.
Read more5th March 2019
Dr Ranjit Manchanda from Barts Cancer Institute, Queen Mary University of London, and Consultant Gynaecological Oncologist at Barts Health NHS Trust, was announced today as one of 13 Fellows to join the NHS […]
Read more27th February 2019
Using flies to reveal mechanisms of cancer development- Q&A with Dr Ribeiro Dr Paulo Ribeiro and his team. From left to right: Paulo Ribeiro, Lauren Dawson, Alberto Rizzo and Damien […]
Read more6th December 2018
UK Health Secretary Matt Hancock announced yesterday that a project involving Queen Mary researchers has reached its goal of sequencing 100,000 whole genomes from NHS patients.
Read more9th October 2018
BCI researchers are lead members of an international team to be funded by an Accelerator Award, which will bring together scientists from the UK, Spain and Italy in a bid to improve early detection and intervention of blood cancers.
Read more